FDA and DEA Regulation of Opioid Drugs and the Opioid Crisis 2022 - McDermott Will & Emery

FDA and DEA Regulation of Opioid Drugs and the Opioid Crisis 2022

Overview


Brian Malkin joins the DC Bar for their event, “FDA and DEA Regulation of Opioid Drugs and the Opioid Crisis 2022.” Brian and panel will cover, the regulation of opioid drugs and the legal issues involved in combating this crisis in the United States. The panel will also discuss how the US Drug Enforcement Administration (DEA) schedules opioid drugs and develops annual quotas and prevents diversion, and how pain and substance abuse treatment doctors from the American Medical Association’s perspective view these important regulatory issues and interact with the regulators at the FDA and DEA.

Learn more and register here.

Dig Deeper

Webinar / McDermott IP Focus / March 2, April 6 and April 21, 2023

McDermott IP Focus 2023

San Francisco, CA / McDermott Event / January 10, 2023

McDermott at the 2023 J.P. Morgan Healthcare Conference